Belite Bio (BLTE) Shares Outstanding (Weighted Average) (2020 - 2025)

Belite Bio has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $33.5 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 9.82% year-over-year to $33.5 million; the trailing twelve-month figure through Dec 2025 stood at $33.5 million (up 9.82% YoY), and the FY2025 full-year result was $33.5 million, up 9.82% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $33.5 million, up from $30.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $33.5 million in Q4 2025, with the low at $169302.0 in Q4 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $20.1 million, with a median of $26.6 million recorded in 2023.
• Year-over-year, Shares Outstanding (Weighted Average) plunged 98.23% in 2022 and surged 15607.83% in 2023.
• Tracing BLTE's Shares Outstanding (Weighted Average) over 5 years: stood at $9.6 million in 2021, then sank by 98.23% to $169302.0 in 2022, then surged by 15607.83% to $26.6 million in 2023, then advanced by 14.83% to $30.5 million in 2024, then increased by 9.82% to $33.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $33.5 million (Q4 2025), $30.5 million (Q4 2024), and $26.6 million (Q4 2023), per Business Quant data.

Peer Comparison